Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Human pluripotent reprogramming with CRISPR activators

Open access

Published version of a preprint

Abstract

CRISPR-Cas9-based gene activation (CRISPRa) is an attractive tool for cellular reprogramming applications due to its high multiplexing capacity and direct targeting of endogenous loci. Here we present the reprogramming of primary human skin fibroblasts into induced pluripotent stem cells (iPSCs) using CRISPRa, targeting endogenous OCT4 , SOX2 , KLF4 , MYC , and LIN28A promoters. The low basal reprogramming efficiency can be improved by an order of magnitude by additionally targeting a conserved Alu-motif enriched near genes involved in embryo genome activation (EEA-motif). This effect is mediated in part by more efficient activation of NANOG and REX1 . These data demonstrate that human somatic cells can be reprogrammed into iPSCs using only CRISPRa. Furthermore, the results unravel the involvement of EEA-motif-associated mechanisms in cellular reprogramming.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-05067-x

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 CRISPRa-mediated reprogramming of NSCs and EEA-motif targeting. a Schematic representation of dCas9VPH structure. b Schematic representation of NSC reprogramming into iPSCs with dCas9VPH mediated OCT4 activation. c Immunocytochemical detection of pluripotency markers in NCS-derived iPSCs (top row) and tri-lineage differentiation in plated embryoid bodies (bottom row). Nuclei stained blue. Scale bar = 200 µm. d Targeting of EGA enriched Alu-motif with SpdCas9 gRNAs. e Quantification of iPSC-like alkaline phosphatase positive colonies induced from NSCs. n = 6 independent inductions (P = 0.053, OCT4 targeting with EEA-gRNAs vs. without EEA-gRNAs). Data presented as mean ± s.e.m., two-tailed Student’s t-test
Fig. 1 CRISPRa-mediated reprogramming of NSCs and EEA-motif targeting. a Schematic representation of dCas9VPH structure. b Schematic representation of NSC reprogramming into iPSCs with dCas9VPH mediated OCT4 activation. c Immunocytochemical detection of pluripotency markers in NCS-derived iPSCs (top row) and tri-lineage differentiation in plated embryoid bodies (bottom row). Nuclei stained blue. Scale bar = 200 µm. d Targeting of EGA enriched Alu-motif with SpdCas9 gRNAs. e Quantification of iPSC-like alkaline phosphatase positive colonies induced from NSCs. n = 6 independent inductions (P = 0.053, OCT4 targeting with EEA-gRNAs vs. without EEA-gRNAs). Data presented as mean ± s.e.m., two-tailed Student’s t-testCC BY · PubMed Central
Fig. 2 Optimization of dCas9 activator and gRNA targeting in HEK293 for reprogramming factor activation. a Locations of promoter targeting gRNAs for reprogramming factors (OCT4, SOX2, KLF4, C-MYC, LIN28A, and NANOG) in relation to transcription start site. b Immunocytochemical staining of reprogramming factors after single gRNA activation and pooled mixture of five guides in HEK293 with dCas9VPH. Pictures are in similar order to guides in Fig. 2a. Best performing guides used for plasmid cloning are marked with dotted lines. Scale bar = 400 µm. c Schematic representation of concatenated reprogramming factor gRNA plasmid construction. d Reprogramming factor activation by qRT-PCR, in HEK293 cells 3 days after transfection and HFFs 4 days after electroporation, using transiently expressed dCas9VPH effector. n = 3, data are from three independently treated samples. Data presented as mean ± s.e.m., two tailed Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 2 Optimization of dCas9 activator and gRNA targeting in HEK293 for reprogramming factor activation. a Locations of promoter targeting gRNAs for reprogramming factors (OCT4, SOX2, KLF4, C-MYC, LIN28A, and NANOG) in relation to transcription start site. b Immunocytochemical staining of reprogramming factors after single gRNA activation and pooled mixture of five guides in HEK293 with dCas9VPH. Pictures are in similar order to guides in Fig. 2a. Best performing guides used for plasmid cloning are marked with dotted lines. Scale bar = 400 µm. c Schematic representation of concatenated reprogramming factor gRNA plasmid construction. d Reprogramming factor activation by qRT-PCR, in HEK293 cells 3 days after transfection and HFFs 4 days after electroporation, using transiently expressed dCas9VPH effector. n = 3, data are from three independently treated samples. Data presented as mean ± s.e.m., two tailed Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 3 EEA-motif targeting enhances derivation of CRISPRa iPSCs from primary skin fibroblasts. a Schematic representation of skin fibroblast reprogramming with dCas9 activators. b Pluripotency factor expression in CRISPR-iPSC colonies (top row, scale bar = 400 µm) and tri-lineage differentiation markers for ectoderm (TUBB3), mesoderm (Vimentin and α-SMA), and endoderm (SOX17 and FOXA2) in embryoid bodies (middle row, scale bar = 200 µm) and teratomas (bottom row, scale bar = 800 µm). c Normal 46, XX karyotype of a CRISPRa iPSC line HEL139.2. d Principal component analysis of CRISPR iPSC lines, control PSC lines and HFFs based on expression of 123 significantly fluctuated genes. e Clustering of iPSC lines and HFFs based on expression of 85 significantly fluctuated and differentially regulated genes. f Clustering of CRISPR iPSC lines and control pluripotent stem cells based on DNA methylation. g Effect of VP192 and VPH domains and EEA-motif targeting on CRISPRa reprogramming efficiency of HFFs. n = 6 from three independent experiments. Data presented as mean ± s.e.m., two tailed Student’s t-test. **P < 0.01
Fig. 3 EEA-motif targeting enhances derivation of CRISPRa iPSCs from primary skin fibroblasts. a Schematic representation of skin fibroblast reprogramming with dCas9 activators. b Pluripotency factor expression in CRISPR-iPSC colonies (top row, scale bar = 400 µm) and tri-lineage differentiation markers for ectoderm (TUBB3), mesoderm (Vimentin and α-SMA), and endoderm (SOX17 and FOXA2) in embryoid bodies (middle row, scale bar = 200 µm) and teratomas (bottom row, scale bar = 800 µm). c Normal 46, XX karyotype of a CRISPRa iPSC line HEL139.2. d Principal component analysis of CRISPR iPSC lines, control PSC lines and HFFs based on expression of 123 significantly fluctuated genes. e Clustering of iPSC lines and HFFs based on expression of 85 significantly fluctuated and differentially regulated genes. f Clustering of CRISPR iPSC lines and control pluripotent stem cells based on DNA methylation. g Effect of VP192 and VPH domains and EEA-motif targeting on CRISPRa reprogramming efficiency of HFFs. n = 6 from three independent experiments. Data presented as mean ± s.e.m., two tailed Student’s t-test. **P < 0.01CC BY · PubMed Central
Fig. 4 Transcriptional analysis of reprogramming cell populations. a Schematic representation of skin fibroblast reprograming with dCas9VP192 for RNA sequencing samples. b Clustering of all reprogramming samples based on expression of 4972 significantly fluctuated genes. Group 6 represents genes upregulated specifically by EEA-guides at day 12. c Upregulated genes at day 12 of reprogramming in OMKSL + KM + EEA targeted cells (Group 6). d Clustering of samples within day 4, 8, and 12 time points based on differentially regulated genes
Fig. 4 Transcriptional analysis of reprogramming cell populations. a Schematic representation of skin fibroblast reprograming with dCas9VP192 for RNA sequencing samples. b Clustering of all reprogramming samples based on expression of 4972 significantly fluctuated genes. Group 6 represents genes upregulated specifically by EEA-guides at day 12. c Upregulated genes at day 12 of reprogramming in OMKSL + KM + EEA targeted cells (Group 6). d Clustering of samples within day 4, 8, and 12 time points based on differentially regulated genesCC BY · PubMed Central
Fig. 5 EEA-motif targeting improves NANOG and REX1 activation. a Immunostaining of emerging iPSC colonies detects activation of targeted LIN28A before its mRNA reads become detectable in bulk RNA-seq. Scale bar = 400 µm. b HFF reprogramming efficiency after transgenic expression of additional factors belonging to Group 6 (Fig. 4c). n = 5, three independent experiments. c qRT-PCR quantification of NANOG and REX1 activation using dCas9VP192 with and without EEA-motif gRNAs in HEK293. n = 3, three independent experiments. d NANOG activation can be detected by immunostaining in CRISPRa reprogramming colonies 2 days earlier in the presence of EEA-motif targeting guides. Scale bar = 200 µm. Data presented as mean ± s.e.m., two tailed Student’s t-test. **P < 0.01, ***P < 0.001
Fig. 5 EEA-motif targeting improves NANOG and REX1 activation. a Immunostaining of emerging iPSC colonies detects activation of targeted LIN28A before its mRNA reads become detectable in bulk RNA-seq. Scale bar = 400 µm. b HFF reprogramming efficiency after transgenic expression of additional factors belonging to Group 6 (Fig. 4c). n = 5, three independent experiments. c qRT-PCR quantification of NANOG and REX1 activation using dCas9VP192 with and without EEA-motif gRNAs in HEK293. n = 3, three independent experiments. d NANOG activation can be detected by immunostaining in CRISPRa reprogramming colonies 2 days earlier in the presence of EEA-motif targeting guides. Scale bar = 200 µm. Data presented as mean ± s.e.m., two tailed Student’s t-test. **P < 0.01, ***P < 0.001CC BY · PubMed Central
Fig. 6 EGA-enriched Alu-motif targeting is associated with activation and chromatin opening. a Effect of single EEA-motif targeting gRNAs (Fig. 1e) on CRISPRa reprogramming efficiency of HFFs. n = 3, data are from three independent experiments. b Schematic representation of EEA-motif reporter plasmid activation. c qRT-PCR quantification of mCherry reporter activation with EEA-motif gRNAs 1 and 2 in reporter transfected HEK293 relative to five gRNAs. EEA-g1 activates the reporter with higher efficiency than EEA-g2 (P = 0.02). n = 3, three independent experiments. d Expression of Alu derived transcripts in STRT-seq data of pluripotent stem cells and CRISPRa reprogramming cell populations. Centre line, box, and whiskers represent median, quartiles, and 1.5 IQR, respectively. e Effect of dCas9 fusion domain on reprogramming efficiency in transgenic reprogramming with OCT4, SOX2, KLF4, LIN28, L-MYC, and EEA-g1. n = 6, data are from three independent experiments. f Increase in the presence of EEA-g1 sequence in ATAC-seq peaks in TetON-DDdCas9GFP and EEA-g1 expressing HEK293. ctrl n = 3, DOX + TMP n = 5. g Effect of dCas9 fusion domain on reprogramming efficiency in transgenic reprogramming with OCT4, SOX2, LIN28, L-MYC, and EEA-g1. n = 6, data are from three independent experiments. h Schematic model of EEA-motif targeting in gene activation and reprogramming. Data presented as mean ± s.e.m., two tailed Student’s t-test. *P < 0.05, **P < 0.01
Fig. 6 EGA-enriched Alu-motif targeting is associated with activation and chromatin opening. a Effect of single EEA-motif targeting gRNAs (Fig. 1e) on CRISPRa reprogramming efficiency of HFFs. n = 3, data are from three independent experiments. b Schematic representation of EEA-motif reporter plasmid activation. c qRT-PCR quantification of mCherry reporter activation with EEA-motif gRNAs 1 and 2 in reporter transfected HEK293 relative to five gRNAs. EEA-g1 activates the reporter with higher efficiency than EEA-g2 (P = 0.02). n = 3, three independent experiments. d Expression of Alu derived transcripts in STRT-seq data of pluripotent stem cells and CRISPRa reprogramming cell populations. Centre line, box, and whiskers represent median, quartiles, and 1.5 IQR, respectively. e Effect of dCas9 fusion domain on reprogramming efficiency in transgenic reprogramming with OCT4, SOX2, KLF4, LIN28, L-MYC, and EEA-g1. n = 6, data are from three independent experiments. f Increase in the presence of EEA-g1 sequence in ATAC-seq peaks in TetON-DDdCas9GFP and EEA-g1 expressing HEK293. ctrl n = 3, DOX + TMP n = 5. g Effect of dCas9 fusion domain on reprogramming efficiency in transgenic reprogramming with OCT4, SOX2, LIN28, L-MYC, and EEA-g1. n = 6, data are from three independent experiments. h Schematic model of EEA-motif targeting in gene activation and reprogramming. Data presented as mean ± s.e.m., two tailed Student’s t-test. *P < 0.05, **P < 0.01CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 181

Metadata

Authors
Weltner, J., Balboa, D., Katayama, S., Bespalov, M., Krjutškov, K., Jouhilahti, E.-M., Trokovic, R., Kere, J., & Otonkoski, T.
Affiliations
  • University of Helsinki (FI)
  • Karolinska Institutet (SE)
  • Guy's Hospital (GB)
Corresponding author
  • Weltner, Jere
  • Kere, Juha
  • Otonkoski, Timo
Venue
Nature Communications
Published
2018-07-06
Volume
9
Issue
1
Pages
2643-2643
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2765888851
Cited by
181
References
52
Citations by year
2026: 17 · 2025: 18 · 2024: 19 · 2023: 15 · 2022: 24 · 2021: 33 · 2020: 25 · 2019: 24 · 2018: 5
FWCI
7.70
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
Funders
  • Helsingin Yliopisto
  • Tekes (40395/13)
  • Jane ja Aatos Erkon Säätiö
  • Knut och Alice Wallenbergs Stiftelse (KAW2015, KAW 2015.0096)
  • Novo Nordisk
  • Sigrid Juséliuksen Säätiö
  • Instrumentariumin Tiedesäätiö
  • Novo Nordisk Fonden (NNF16OC0021090, NNF15OC0016426)
  • Uppsala Multidisciplinary Center for Advanced Computational Science (b2014069)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
CRISPR activation, gene activation, cellular reprogramming, induced pluripotent stem cells, dermal fibroblasts, Oct4, SOX2, KLF4, c-Myc, LIN28A, Nanog, Rex1, pluripotency genes
MeSH terms
Nanog Homeobox Protein, CRISPR-Associated Protein 9, Kruppel-Like Factor 4, RNA, Guide, CRISPR-Cas Systems, Base Sequence, Embryo, Mammalian, Fibroblasts, Humans, Male, Transcription, Genetic, Gene Expression Regulation, Developmental, Alu Elements, Induced Pluripotent Stem Cells, HEK293 Cells, Neural Stem Cells, Nucleotide Motifs, Clustered Regularly Interspaced Short Palindromic Repeats, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human pluripotent reprogramming with CRISPR activators. https://app.cochat.ai/papers/10.1038/s41467-018-05067-x
The paper
Weltner, J., Balboa, D., Katayama, S., Bespalov, M., Krjutškov, K., Jouhilahti, E.-M., Trokovic, R., Kere, J., & Otonkoski, T. (2018). Human pluripotent reprogramming with CRISPR activators. Nature Communications. https://doi.org/10.1038/s41467-018-05067-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.